PPBT
Purple Biotech
PPBT
PPBT
5 hedge funds and large institutions have $242K invested in Purple Biotech in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
$128K |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
$47K |
| 3 |
VF
Virtu Financial
New York
|
$31K |
Top Sellers
| 1 |
TSS
Two Sigma Securities
New York
|
$0 |
| 2 |
UBS Group
Zurich,
Switzerland
|
$10K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $128K | +$128K | +243 | New |
|
|
EIM
2
Essex Investment Management
Boston,
Massachusetts
| $47K | +$47K | +89 | New |
|
|
VF
3
Virtu Financial
New York
| $31K | +$31K | +58 | New |
|
4
Wells Fargo
San Francisco,
California
| $26K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $10K | -$2.78K | -5 | -22% |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$23K | -53 | Closed |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| – | -$1K | -2 | Closed |
|